Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Xponance Inc.

Xponance Inc. lessened its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 8.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,345 shares of the business services provider’s stock after selling 714 shares during the quarter. Xponance Inc.’s holdings in Exponent were worth $647,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Kayne Anderson Rudnick Investment Management LLC grew its position in shares of Exponent by 9.5% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,685,472 shares of the business services provider’s stock worth $401,076,000 after acquiring an additional 408,295 shares in the last quarter. Invesco Ltd. grew its position in shares of Exponent by 89.4% in the 3rd quarter. Invesco Ltd. now owns 594,343 shares of the business services provider’s stock worth $50,876,000 after acquiring an additional 280,600 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Exponent by 33.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 458,946 shares of the business services provider’s stock worth $39,286,000 after acquiring an additional 114,853 shares in the last quarter. Fenimore Asset Management Inc. acquired a new position in shares of Exponent in the 3rd quarter worth approximately $9,091,000. Finally, Ameriprise Financial Inc. grew its position in shares of Exponent by 11.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 693,259 shares of the business services provider’s stock worth $59,343,000 after acquiring an additional 71,074 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Stock Performance

Shares of EXPO stock opened at $95.21 on Friday. Exponent, Inc. has a 1 year low of $64.61 and a 1 year high of $102.72. The stock has a fifty day moving average of $79.93 and a two-hundred day moving average of $81.94. The firm has a market capitalization of $4.82 billion, a PE ratio of 48.83 and a beta of 0.68.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.13. Exponent had a return on equity of 28.49% and a net margin of 18.69%. The company had revenue of $137.21 million during the quarter, compared to analyst estimates of $125.98 million. During the same quarter in the previous year, the firm posted $0.56 EPS. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. Equities research analysts predict that Exponent, Inc. will post 1.76 earnings per share for the current fiscal year.

Exponent Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, March 8th were given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.18%. The ex-dividend date of this dividend was Thursday, March 7th. This is a positive change from Exponent’s previous quarterly dividend of $0.26. Exponent’s payout ratio is 57.44%.

Analysts Set New Price Targets

EXPO has been the subject of several research reports. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial reduced their price objective on Exponent from $110.00 to $95.00 and set a “buy” rating for the company in a research report on Friday, February 2nd.

Insiders Place Their Bets

In other news, insider Eric Guyer sold 3,367 shares of the company’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $78.49, for a total value of $264,275.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is currently owned by insiders.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.